Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial

Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A minor update to the ClinicalTrials.gov page’s displayed software/version revision number (from v3.5.2 to v3.5.3) occurred, without any visible change to the trial’s study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:45:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added updated contact details for study staff (e.g., Matthew Mei, MD; Ranjana Advani, MD) and new location information for Stanford University Medical Center and City of Hope Cancer Center, and revised total study locations from 8 to 10.
    Difference
    0.9%
    Check dated 2026-04-17T02:12:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. This change is a metadata/versioning update and does not alter the study details or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-03-18T22:51:19.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T20:04:47.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A minor site-wide revision (Revision: v3.4.2) was added, and the interim funding-status notice along with the previous revision entry (Revision: v3.4.1) were removed. There are no changes to study content or user interactions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T04:43:45.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a site-wide notice regarding government funding and NIH Clinical Center status. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:30:47.000Z thumbnail image

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.